Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Iron Oxide as an MRI Contrast Agent for Cell Tracking.
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
OCT: New perspectives in neuro-ophthalmology.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
[Toxic demyelinating neuropathy and leukoencephalopathy in patients who take the slimming products Thermatrim ® and Pura Alegria ®].
Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Kinetic Characterization of Ebselen, Chelerythrine and Apomorphine as Glutaminase Inhibitors.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
Current Perspectives on Interferon Beta-1b for the Treatment of Multiple Sclerosis.
The association between multiple sclerosis and fracture risk.
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran.
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
A program to facilitate retention of employment among persons with multiple sclerosis.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
The MoSt Project--More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.
Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
Selectins and their ligands as potential immunotherapeutic targets in neurological diseases.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Pages
« first
‹ previous
…
547
548
549
550
551
552
553
554
555
…
next ›
last »